Attachment 3a
MMP Medical Record Abstraction
Medical History Form
Medical Monitoring Project (MMP)
Medical Record Abstraction Form
2012 Medical History Form (MHF)
VERSION 7.1.0
O PTIONAL- FOR LOCAL USE ONLY
M MP MHF v7.1.0 Abstraction MMP Participant ID: Facility ID: (ID of the facility where abstraction is being conducted)
Medical record number:
Patient name:
Patient residence:
Street:
City/County: State:
ZIP code:
Physician name: |
DEPARTMENT OF HEALTH AND
HUMAN SERVICES Centers
for Disease Control & Prevention
M edical Monitoring Project (MMP)
Medical Record Abstraction Form
2012 Medical History Form (MHF) v7.1.0
I. ABSTRACTION AND IDENTIFICATION |
||
MMP Participant ID: |
||
Surveillance Period (SP)
SP start date:
(12 months prior to date of interview OR 1st contact attempt if no interview obtained) |
SP end date:
(date of interview OR 1st contact attempt if no interview obtained)
|
|
Medical History Period (MHP)
MHP start date: (date of first HIV care (at any facility) documented in this medical record)
First visit to this facility: (date of first available visit to this facility for HIV care)
MHP end date: (day before the SP start date)
OR
No documented care in medical records prior to SP start date Complete sections I, II, and IX (documentation of the first positive HIV test result)
|
||
Abstraction Facility ID:
(ID of the facility where abstraction is being conducted)
|
For the medical history period Abstract information on all HIV care documented in the medical records at the “Abstraction Facility” using a single MHF regardless of where the care was actually provided to the patient. |
|
Date of abstraction: Abstractor ID:
Mo.
Day
Year |
||
II. PATIENT DEMOGRAPHICS |
||
Date of birth: Date not documented
Mo.
Day
Year
If date of birth is not documented, enter documented age:
Enter date of this documented age: Date not documented
Mo.
Year |
||
Most recent height (ft/in) prior to the SP start date:
Enter date of this documented height: Date not documented
ft.
inches
Height not documented |
||
Sex at birth: Male Not documented (select one) Female |
||
Gender: Male Male to female Not documented (select one) Female Female to male |
II. PATIENT DEMOGRAPHICS cont’d |
|||
Hispanic or Latino ethnicity: Yes, Hispanic or Latino Not documented (select one) No, not Hispanic or Latino
|
|||
Race: 1 American Indian or Alaska Native (select all that are documented) 2 Asian 3 Black or African American 4 Native Hawaiian or Other Pacific Islander 5 White
6 Not documented |
|||
Country of birth: 1 United States (select one) 2 US Dependencies/Possessions (including Puerto Rico)
3 Other, Specify:
4 Not documented
|
|||
III. MEDICAL HISTORY FORM SECTIONS - OPTIONAL |
|||
Is there documentation of any of the following prior to the SP start date? Yes Select all that are documented below. No This form is now complete except for optional section XIII (Remarks).
|
|||
Diagnosis of AIDS defining opportunistic illnesses (AIDS OI) Complete section IV. |
First positive HIV test result, or laboratory test results for CD4 cell count, HIV viral load, or abnormal ALT (SGPT) or AST (SGOT) Complete section IX. |
||
Prescription for prophylaxis of Pneumocystis jiroveci pneumonia (PCP) or Mycobacterium avium complex (MAC) Complete section V. |
Testing for HIV ART resistance Complete section X. |
||
Screening for hepatitis (A, B, or C), Toxoplasma, or tuberculosis (TB) Complete section VI. |
Reported or suspected substance abuse, including substance abuse counseling or treatment Complete section XI. |
||
Whether or not hepatitis A, B, A and B, or pneumococcal immunizations were given Complete section VII. |
Diagnosis of anxiety, bipolar disorder, psychosis, or depression Complete section XII. |
||
Prescription of antiretroviral therapy (ART) Complete section VIII. |
|
||
IV. AIDS DEFINING OPPORTUNISTIC ILLNESSES (AIDS OI) |
|||
Is there documentation that any AIDS defining opportunistic illnesses (AIDS OI) were diagnosed prior to the SP start date? Yes Enter all that are documented below. No |
|||
AIDS defining opportunistic illnesses (AIDS OI) prior to the SP start date (select all that are documented and record dates)
|
Date of first diagnosis
|
Date not documented |
|
1 Candidiasis, bronchi, trachea, or lungs |
|
1 |
|
2 Candidiasis, esophageal |
|
2 |
|
3 Carcinoma, invasive cervical |
|
3 |
|
4 Coccidioidomycosis, disseminated or extrapulmonary |
|
4 |
|
5 Cryptococcosis, extrapulmonary |
|
5 |
IV. AIDS DEFINING OPPORTUNISTIC ILLNESSES (AIDS OI) cont’d |
|||
AIDS defining opportunistic illnesses (AIDS OI) prior to the SP start date (select all that are documented and record dates)
|
Date of first diagnosis
|
Date not documented |
|
6 Cryptosporidiosis, chronic intestinal (>1 month duration) |
|
6 |
|
7 Cytomegalovirus disease (other than in liver, spleen, or nodes) |
|
7 |
|
8 Cytomegalovirus retinitis (with loss of vision) |
|
8 |
|
9 HIV encephalopathy |
|
9 |
|
10 Herpes simplex: chronic ulcer (>1 month duration) or bronchitis, pneumonitis, or esophagitis |
|
10 |
|
11 Histoplasmosis, disseminated or extrapulmonary |
|
11 |
|
12 Isosporiasis, chronic intestinal (>1 month duration) |
|
12 |
|
13 Kaposi’s sarcoma |
|
13 |
|
14 Lymphoma, Burkitt’s (or equivalent term) |
|
14 |
|
15 Lymphoma, immunoblastic (IBL, or equivalent term) |
|
15 |
|
16 Lymphoma, primary in brain |
|
16 |
|
17 Mycobacterium avium complex or M. kansasii, disseminated or Extrapulmonary |
|
17 |
|
18 M. tuberculosis, pulmonary |
|
18 |
|
19 M. tuberculosis, disseminated or extrapulmonary |
|
19 |
|
20 Mycobacterium, of other species or unidentified species, disseminated or extrapulmonary |
|
20 |
|
21 Pneumocystis jiroveci pneumonia (PCP) |
|
21 |
|
22 Pneumonia, recurrent in 12 month period |
|
22 |
|
23 Progressive multifocal leukoencephalopathy (PML) |
|
23 |
|
24 Salmonella septicemia, recurrent |
|
24 |
|
25 Toxoplasmosis of brain |
|
25 |
|
26 Wasting syndrome due to HIV |
|
26 |
|
V. PROPHYLAXIS |
|||
Is there documentation of prescription for prophylaxis of Pneumocystis jiroveci pneumonia (PCP) prior to the SP start date? Yes No
Prescription must be for PCP prophylaxis. Medications include: Bactrim® (Septra, Cotrim, Co-trimoxazole, trimethorprim, sulfamethoxazole) Dapsone® Pentamidine® (pentamidine isothianate) Mepron® or Mepron® Suspension (atovaquone) Clindamycin® (clindamycin hydrochloride) + Primaquine® (primaquine phosphate) Dapsone® + Daraprim® (pyrimethamine) + Folinic Acid
|
Is there documentation of prescription for prophylaxis of Mycobacterium avium complex (MAC) prior to the SP start date? Yes No
Prescription must be for MAC prophylaxis. Medications include: Biaxin Filmtab® (clarithromycin) Biaxin Granules® Biaxin XL® Zithromax® Zithromax Single Pack® (azithromycin, azithromycin dihydrate) Mycobutin® (rifabutin)
|
VI. HEPATITIS, TOXOPLASMA, AND TUBERCULOSIS (TB) SCREENING |
||||
Is there documentation of screening for hepatitis A, B, C, Toxoplasma, or tuberculosis (TB) prior to the SP start date? Yes Enter all that are documented for each screening below. No |
||||
Was hepatitis A screening performed prior to the SP start date? (select one)
1 Yes – screening done Enter all that are documented for “Yes” below
2 No – documented that screening not done
3 Hepatitis A screening not documented |
||||
If “Yes,” what were the results?
Select all that apply OR result not documented
|
||||
Positive
|
Date of 1st positive test:
Date not documented |
Which Hepatitis A test(s) was/were positive on this date? (select all that apply)
Anti HAV IgG or HAV Ab IgG Anti HAV total or HAV Ab total
Anti-HAV IgM or HAV Ab IgM Test type not documented |
||
Negative
|
Date of last negative test:
Date not documented |
|
||
Result not documented |
||||
Was hepatitis B screening performed prior to the SP start date? (select one)
1 Yes – screening done Enter all that are documented for “Yes” below
2 No – documented that screening not done
3 Hepatitis B screening not documented |
||||
If “Yes,” what were the results?
Select all that apply OR result not documented
|
||||
Positive
|
Date of 1st positive test:
Date not documented |
Which Hepatitis B test(s) was/were positive on this date? (select all that apply)
Anti HBc IgG Anti HBs IgG or HBsAb IgG
Anti HBc IgM Anti HBs or HBsAb total
Anti HBc total HBsAg
Test type not documented |
||
Negative
|
Date of last negative test:
Date not documented |
|
||
Result not documented |
||||
Was hepatitis C screening performed prior to the SP start date? (select one)
1 Yes – screening done Enter all that are documented for “Yes” below
2 No – documented that screening not done
3 Hepatitis C screening not documented |
||||
If “Yes,” what were the results?
Select all that apply OR result not documented |
||||
Positive
|
Date of 1st positive test:
Date not documented |
Which Hepatitis C test(s) was/were positive on this date? (select all that apply)
Anti HCV (EIA or RIBA) HCV RNA quantitative (PCR)
HCV RNA qualitative Test type not documented |
||
Negative
|
Date of last negative test:
Date not documented |
|
||
Result not documented |
VI. HEPATITIS, TOXOPLASMA, AND TUBERCULOSIS (TB) SCREENING cont’d |
||||||||
Was Toxoplasma screening performed prior to the SP start date? (select one)
1 Yes – screening done Enter all that are documented below.
2 No – documented that screening not done
3 Toxoplasma screening not documented
Was there a positive result for the most recent Toxoplasma antibody titer prior to the SP start date? (select one)
1 Yes Enter date of positive result: Date not documented
2 No (negative result for most recent test)
3 Result not documented |
||||||||
Was screening for tuberculosis (TB) performed prior to the SP start date? (select one)
1 Yes – screening done Enter all that are documented below.
2 No – documented that screening not done
3 TB screening not documented
Date of the most recent tuberculin skin test (TST/PPD/Mantoux) or QuantiFERON test (QFT) prior to the SP start date:
Date not documented
Result of the most recent TST/PPD/Mantoux or QFT prior to the SP start date: (enter one for TST/PPD/Mantoux OR one for QFT) |
||||||||
TST/PPD/Mantoux: (enter OR select one)
Result in millimeters: 1 Positive, no value reported
2 Negative, no value reported
3 Not read
4 Anergic
5 Not documented |
OR
|
QFT: (select one)
1 QFT positive
2 QFT negative
3 QFT indeterminate
4 Not documented |
||||||
VII. HEPATITIS AND PNEUMOCOCCAL IMMUNIZATIONS |
||||||||
Is there documentation of whether or not hepatitis A, B, A and B, or pneumococcal immunizations were given prior to the SP start date? Yes Enter all that are documented for each vaccine below. No |
||||||||
Was hepatitis A vaccine (Havrix, Vaqta) given prior to the SP start date? (select one: Yes, No, or Not documented) |
||||||||
1 Yes |
Enter a maximum of 3 documented doses and dates: Dose No. (If documented) Date |
Date not documented |
||||||
2 Yes – but number of doses not documented |
_____
|
|
||||||
3 No – documented that vaccine not given |
||||||||
|
Reason vaccine not given: (select one) |
_____ |
|
|||||
|
|
Prior vaccination |
|
Patient declined |
||||
|
|
Previously infected |
|
Not documented |
||||
|
|
Other, specify |
_____
|
|
||||
|
|
|||||||
4 Hepatitis A vaccination not documented
|
|
|
VII. HEPATITIS AND PNEUMOCOCCAL IMMUNIZATIONS cont’d |
|
||||||||
Was hepatitis B vaccine (Energix B, Recombivax) given prior to the SP start date? (select one: Yes, No, or Not documented) |
|
||||||||
1 Yes |
Enter a maximum of 4 documented doses and dates: Dose No. (If documented) Date |
Date not documented |
|
||||||
2 Yes – but number of doses not documented |
_____
|
|
|
||||||
3 No – documented that vaccine not given |
|
||||||||
|
Reason vaccine not given: (select one) |
_____ |
|
|
|||||
|
|
Prior vaccination |
|
Patient declined |
|
||||
|
|
Previously infected |
|
Not documented |
|
||||
|
|
Other, specify |
_____ |
|
|
||||
|
|
|
|||||||
_____
|
|
|
|||||||
4 Hepatitis B vaccination not documented |
|
||||||||
|
|
|
|||||||
Was combination hepatitis A and B vaccine (Twinrix) given prior to the SP start date? (select one: Yes, No, or Not documented) |
|
|
|||||||
1 Yes |
Enter a maximum of 4 documented doses and dates: Dose No. (If documented) Date |
Date not documented |
|
||||||
2 Yes – but number of doses not documented |
_____
|
|
|
||||||
3 No – documented that vaccine not given |
|
||||||||
|
Reason vaccine not given: (select one) |
_____
|
|
|
|||||
|
|
Prior vaccination |
|
Patient declined |
|
||||
|
|
Previously infected |
|
Not documented |
|
||||
|
|
Other, specify |
_____
|
|
|
||||
|
|
|
|||||||
|
|
|
|||||||
_____
|
|
|
|||||||
4 Hepatitis A and B vaccination not documented |
|
||||||||
|
|
|
|||||||
Was pneumococcal vaccine (Pneumovax 23, Pneu-Immune 23) given prior to the SP start date? (select one Yes, No, or Not documented) |
|
||||||||
1 Yes |
Enter date of last dose given before the SP start date: |
Mo.
Year
|
Date not documented |
|
|||||
2 No – documented that vaccine not given |
|
|
|
||||||
|
Reason vaccine not given: (select one) |
|
|||||||
|
|
Prior vaccination |
|
Patient declined |
|
|
|
||
|
|
|
|
Not documented |
|
||||
|
|
Other, specify |
|
||||||
|
|
|
|||||||
3 Pneumococcal vaccination not documented |
|
|
VIII. ANTIRETROVIRAL THERAPY (ART) |
||||
Is there documentation of prescription of antiretroviral therapy (ART) prior to the SP start date? Yes Enter all that that are documented below. No |
||||
Date of first prescribed antiretroviral medication: Date not documented
Prescribed antiretroviral medications prior to the SP start date: (select all that are documented) |
||||
1 Abacavir (ABC, Ziagen) |
9 Efavirenz (EFV, Sustiva) |
17 Lopinavir/Ritonavir (LPV/RTV, Kaletra, Meltrex) |
25 Tenofovir (TDF, Viread) |
|
2 Amprenavir (APV, Agenerase) |
10 Emtricitabine (FTC, Emtriva) |
18 Maraviroc (MRC, Selzentry) |
26 Tipranavir (TPV, Aptivus) |
|
3 Atazanavir (ATV, Reyataz) |
11 Enfuvirtide (ENF, T-20, Fuzeon) |
19 Nelfinavir (NFV, Viracept) |
27 Trizivir (ABC/3TC/AZT) |
|
4 Atripla (EFV/FTC/TDF) |
12 Epzicom (ABC/3TC) |
20 Nevirapine (NVP, Viramune) |
28 Truvada (FTC/TDF) |
|
5 Combivir (AZT/3TC) |
13 Etravirine (Intelence, ETR, formerly TMC125) |
21 Raltegravir (RAL, Isentress, MK-0518) |
29 Zalcitabine (ddC, Hivid) |
|
6 Darunavir (DRV, TMC 114, Prezista) |
14 Fosamprenavir (FPV, Lexiva) |
22 Ritonavir (RTV, Norvir) |
30 Zidovudine (AZT, Retrovir) |
|
7 Delavirdine (DLV, Rescriptor) |
15 Indinavir (IDV, Crixivan) |
23 Saquinavir (SQV-HGC, Invirase, Fortovase) |
|
|
8 Didanosine (ddl) Videx |
16 Lamivudine (3TC, Epivir) |
24 Stavudine (d4T, Zerit) |
|
|
31 Other, Specify: |
||||
3 2 Other, Specify: |
||||
3 3 Other, Specify: |
||||
3 4 Other, Specify: |
||||
IX. LABORATORY TEST RESULTS |
||||
Is there documentation of the first positive HIV test result, or laboratory test results for CD4 cell count, or HIV viral load, prior to the SP start date? Yes Enter all that are documented for each diagnosis or test below. No |
||||
Is there documentation of the first positive HIV test result?
Yes Enter date of first positive HIV test: Date not documented |
||||
No
|
|
|||
Is there documentation of CD4 cell count test results prior to the SP start date?
Yes Lowest CD4 cell count: / µl or mm3 |
||||
No
|
Date of lowest CD4 cell count: Date not documented
|
|||
Is there documentation of HIV viral load (VL) test results prior to the SP start date?
Yes Is there documentation of an undetectable VL?
|
||||
No
|
Yes Enter date of most recent undetectable result: Date not No documented |
X. HIV ART RESISTANCE TESTING |
||
Is there documentation of HIV ART resistance testing prior to the SP start date? Yes Select all that are documented for each resistance test below. No |
||
Was genotypic ART resistance testing performed prior to the SP start date? (Select one: Yes, No, or Testing not documented) |
||
|
Select all ART classes documented with resistance and/or possible resistance: |
|
1 Yes – resistance reported
|
FI PI NRTI NNRTI ART classes not specified |
|
2 Yes – possible resistance reported
|
FI PI NRTI NNRTI ART classes not specified |
|
3 Yes – but no resistance reported
|
|
|
4 Yes – but result was indeterminate
|
|
|
5 Yes – but test result not documented
|
||
6 No – documented that genotypic resistance testing was not done |
||
7 Genotypic resistance testing not documented
|
||
Was phenotypic ART resistance testing performed prior to the SP start date? (Select one: Yes, No, or Testing not documented) |
||
|
Select all ART classes documented with resistance and/or intermediate resistance: |
|
1 Yes – resistance reported
|
FI PI NRTI NNRTI ART classes not specified |
|
2 Yes – intermediate resistance reported
|
FI PI NRTI NNRTI ART classes not specified |
|
3 Yes – but no resistance reported
|
|
|
4 Yes – but result was indeterminate
|
|
|
5 Yes – but test result not documented
|
||
6 No – documented that phenotypic resistance testing was not done |
||
7 Phenotypic resistance testing not documented
|
||
Was virtual phenotypic ART resistance testing performed prior to the SP start date? (Select one: Yes, No, or Testing not documented) |
||
|
Select all ART classes documented with resistance and/or possible / intermediate resistance reported: |
|
1 Yes – resistance reported
|
FI PI NRTI NNRTI ART classes not specified |
|
2 Yes – possible/intermediate resistance reported
|
FI PI NRTI NNRTI ART classes not specified |
|
3 Yes – but no resistance reported
|
|
|
4 Yes – but result was indeterminate
|
|
|
5 Yes – but test result not documented
|
||
6 No – documented that virtual phenotypic resistance testing was not done |
||
7 Virtual phenotypic resistance testing not documented |
||
XI. SUBSTANCE ABUSE |
||
Is there documentation of reported or suspected alcohol abuse or other non-prescribed use of substances, including counseling or treatment for alcohol and/or substance use/abuse prior to the SP? Yes Enter all that are documented below. No |
||
Alcohol Abuse |
||
Is there documentation of alcohol abuse prior to the SP? Yes No |
||
Other Non-prescribed Use of Substances |
||
Is there evidence of any injection substance use (e.g., track marks) documented prior to the SP? Yes No
|
XI. SUBSTANCE ABUSE cont’d |
|||||||||
Non-prescribed use of substances documented prior to the SP: (select all that are documented and type of use) |
|||||||||
Substance |
Type of Use (select all that apply OR select Not documented) |
||||||||
Injection |
Non-Injection |
Not documented |
|||||||
1 Amphetamines (other than methamphetamines) |
|
|
|
||||||
2 Cocaine (other than crack) |
|
|
|
||||||
3 Crack cocaine |
|
|
|
||||||
4 Ecstasy (MDMA, X) |
|
|
|
||||||
5 GHB |
|
|
|
||||||
6 Hallucinogens such as LSD or mushrooms |
|
|
|
||||||
7 Heroin |
|
|
|
||||||
8 Ketamine (Special K) |
|
|
|
||||||
9 Marijuana |
|
|
|
||||||
10 Methadone |
|
|
|
||||||
11 Methamphetamines |
|
|
|
||||||
12 Painkillers such as Oxycontin, Vicodin or Percocet |
|
|
|
||||||
13 Poppers (amyl nitrate) |
|
|
|
||||||
14 Rohypnol |
|
|
|
||||||
15 Steroids/Hormones |
|
|
|
||||||
16 Tranquilizers such as Valium, Ativan, or Xanax |
|
|
|
||||||
17 Viagra, Levitra or Cialis |
|
|
|
||||||
1 8 Other, Specify: |
|
|
|
||||||
1 9 Other, Specify: |
|
|
|
||||||
2 0 Other, Specify: |
|
|
|
||||||
21 Substance not specified |
|
|
|
||||||
XII. MENTAL HEALTH |
|||||||||
Is there documentation of any of the following mental illnesses prior to the SP start date? Yes Select all that are documented below. No |
|||||||||
1 |
Anxiety disorder (General anxiety disorder, GAD) |
3 |
Depression (Major depression, depressive disorder) |
||||||
2 |
Bipolar disorder |
4 |
Psychosis |
O PTIONAL- FOR LOCAL USE ONLY
MMP MHF v7.1.0
Abstraction
MMP Participant ID: Facility ID:
(ID of the facility where abstraction is being conducted)
XIII. REMARKS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Page
File Type | application/msword |
File Title | Medical monitoring project (MMP) |
Author | Rita Morgan |
Last Modified By | Ptomey, Natasha (CDC/OID/NCHHSTP) (CTR) |
File Modified | 2012-07-26 |
File Created | 2012-07-26 |